Grail to present new NHS-Galleri, PATHFINDER 2 data on Galleri cancer test at EDCC, ESMO 2026
GRAL•Grail said it will present new NHS-Galleri and PATHFINDER 2 data at EDCC on Oct. 6-8, 2026, and additional results at ESMO Congress on Oct. 23-27, 2026.
1. Planned presentations
Grail said the readouts will address the Galleri multi-cancer test’s performance across diverse populations, including racial and ethnic groups. Planned presentations will also cover real-world diagnostic workups, including safety, efficiency, earlier detection potential and fewer emergency cancer diagnoses.
